The spanish pancreatic club recommendations for the diagnosis and treatment of chronic pancreatitis: Part 1 (diagnosis)

Pancreatology

Volumn 13, Issue 1, 2013, Pages 8-17

  Martinez J ^a   Abad Gonzalez A ^a   Aparicio, J R ^a   Aparisi, L ^b   Boadas, J ^c   Boix, E ^d   De Las Heras, G ^e   Dominguez Munoz E ^f   Farre A ^g   Fernandez Cruz L ^h   Gomez L ^a   Iglesias Garcia J ^f   Garcia Malpartida K ⁱ   Guarner, L ^j   Larino Noia J ^f   Lluis F ^a   Lopez A ^k   Molero, X ^j   Moreno Perez O ^a   Navarro, S ^h   Palazon J M ^a   Perez Mateo M ^a   Sabater, L ^b   Sastre, Y ^a   Vaquero, E ^h   De Madaria, E ^a   more..

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b Clinical University Hospital of Valencia   (Spain)

^c Sanitary Consortium of Terrassa   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^j HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^k Service of Digestive Medicine   (Spain)

more..

Author keywords

Chronic pancreatitis; Diagnosis; Exocrine pancreatic insufficiency; Guidelines; Therapy

Indexed keywords

ALCOHOL; CHOLECYSTOKININ; CORTICOSTEROID; GLUCOSE; SECRETIN;

ABDOMINAL RADIOGRAPHY; ALCOHOL ABUSE; ARTICLE; AUTOIMMUNE PANCREATITIS; BODY FAT DISTRIBUTION; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; ECHOGRAPHY; ENDOCRINE PANCREATIC INSUFFICIENCY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAT ABSORPTION COEFFICIENT; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; LOW DRUG DOSE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CALCIFICATION; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS INSUFFICIENCY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SMOKING; TREATMENT DURATION;

EID: 85027934895     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.11.309     Document Type: Article

References (98)

1. Banks PA. Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc 2002;56:S226-30. (Pubitemid 36236848)
2. Raimondo M, Wallace MB. Diagnosis of early chronic pancreatitis by endoscopic ultrasound. Are we there yet? JOP 2004;5:1-7. (Pubitemid 38963762)
3. Warshaw AL, Banks PA, Fernandez-del CC. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998;115:765-76. (Pubitemid 28397313)
4. Mossner J, Keim V, Niederau C, Buchler M, Singer MV, Lankisch PG, et al. Guidelines for therapy of chronic pancreatitis. Consensus Conference of the German Society of Digestive and Metabolic Diseases. Halle 21e23 November 1996. Z Gastroenterol 1998;36:359-67.
5. Tandon RK, Sato N, Garg PK. Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol 2002;17:508-18. (Pubitemid 34534092)
6. Frulloni L, Falconi M, Gabbrielli A, Gaia E, Graziani R, Pezzilli R, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010;42(Suppl. 6): S381-S406.
7. Navarro S, Amador J, Arguello L, Ayuso C, Boadas J, de Las HG, et al. Recommendations of the Spanish Biliopancreatic Club for the treatment of acute pancreatitis. Consensus development conference, Gastroenterol Hepatol 2008;31:366-87.
8. Navarro S, Vaquero E, Maurel J, Bombi JA, De JC, Feliu J, et al. Recommendations for diagnosis, staging and treatment of pancreatic cancer (part I). Grupo Espanol de Consenso en Cancer de Pancreas. Med Clin (Barc) 2010; 134:643-55.
9. Navarro S, Vaquero E, Maurel J, Bombi JA, De JC, Feliu J, et al. Recommendations for diagnosis, staging and treatment of pancreatic cancer (part II). Med Clin (Barc) 2010;134:692-702.
10. NIH Consensus Development Program. In: http://consensus.nih.gov/faqs.htm; 2012.
11. Oxford Center for Evidence-Based Medicine. In: www.cebm.net/index.aspx? o1/41025 2012.
12. Banks PA. Classification and diagnosis of chronic pancreatitis. J Gastroenterol 2007;42(Suppl. 17):148-51. (Pubitemid 46140383)
13. Ammann RW. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas 1997;14:215-21. (Pubitemid 27149044)
14. Otsuki M. Chronic pancreatitis. The problems of diagnostic criteria. Pancreatology 2004;4:28-41. (Pubitemid 38453120)
15. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001;120:682-707. (Pubitemid 32171640)
16. Kinney TP, Freeman ML. Pancreatic imaging: current state of the art. Gastroenterology 2009;136:776-9.
17. Siddiqi AJ, Miller F. Chronic pancreatitis: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR 2007;28: 384-94. (Pubitemid 47419275)
18. Choueiri NE, Balci NC, Alkaade S, Burton FR. Advanced imaging of chronic pancreatitis. Curr Gastroenterol Rep 2010;12:114-20.
19. Balci NC, Alkaade S, Magas L, Momtahen AJ, Burton FR. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP. J Magn Reson Imaging 2008;27:125-31.
20. Miller FH, Keppke AL, Wadhwa A, Ly JN, Dalal K, Kamler VA. MRI of pancreatitis and its complications: part 2, chronic pancreatitis. AJR Am J Roentgenol 2004;183:1645-52. (Pubitemid 44210533)
21. Akisik MF, Aisen AM, Sandrasegaran K, Jennings SG, Lin C, Sherman S, et al. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology 2009;250:103-9.
22. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De BF, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10. (Pubitemid 28337421)
23. Kahl S, Glasbrenner B, Leodolter A, Pross M, Schulz HU, Malfertheiner P. EUS in the diagnosis of early chronic pancreatitis: a prospective follow-up study. Gastrointest Endosc 2002;55:507-11. (Pubitemid 41123501)
24. Lees WR, Vallon AG, Denyer ME, Vahl SP, Cotton PB. Prospective study of ultrasonography in chronic pancreatic disease. Br Med J 1979;1:162-4. (Pubitemid 9085255)
25. Wiersema MJ, Hawes RH, Lehman GA, Kochman ML, Sherman S, Kopecky KK. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy 1993;25:555-64. (Pubitemid 24002729)
26. Catalano MF, Sahai A, Levy M, Romagnuolo J, Wiersema M, Brugge W, et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc 2009;69:1251-61.
27. Stevens T, Lopez R, Adler DG, Al-Haddad MA, Conway J, Dewitt JM, et al. Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis. Gastrointest Endosc 2010;71:519-26.
28. Chong AK, Hawes RH, Hoffman BJ, Adams DB, Lewin DN, Romagnuolo J. Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology. Gastrointest Endosc 2007;65:808-14. (Pubitemid 46629067)
29. Albashir S, Bronner MP, Parsi MA, Walsh RM, Stevens T. Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am J Gastroenterol 2010;105:2498-503.
30. Varadarajulu S, Eltoum I, Tamhane A, Eloubeidi MA. Histopathologic correlates of noncalcific chronic pancreatitis by EUS: a prospective tissue characterization study. Gastrointest Endosc 2007;66:501-9. (Pubitemid 47296317)
31. Wollaeger EE, Comfort MW, Osterberg AE. Total solids, fat and nitrogen in the feces; a study of normal persons taking a test diet containing a moderate amount of fat: comparison with results obtained with normal persons taking a test diet containing a large amount of fat. Gastroenterology 1947;9:272-83.
32. Dornberger GR, Comfort MW. Total fecal solids, fat and nitrogen; a study of patients with chronic relapsing pancreatitis. Gastroenterology 1948;11: 691-700.
33. Lankisch PG, Lembcke B, Wemken G, Creutzfeldt W. Functional reserve capacity of the exocrine pancreas. Digestion 1986;35:175-81. (Pubitemid 16001678)
34. Stevens T, Dumot JA, Parsi MA, Zuccaro G, Vargo JJ. Combined endoscopic ultrasound and secretin endoscopic pancreatic function test in patients evaluated for chronic pancreatitis. Dig Dis Sci 2010;55:2681-7.
35. Weintraub A, Blau H, Mussaffi H, Picard E, Bentur L, Kerem E, et al. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study. J Pediatr Gastroenterol Nutr 2009;48:306-10.
36. Dominguez-Munoz JE, Iglesias-Garcia J, Vilarino-Insua M, Iglesias-Rey M. 13Cmixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007;5:484-8. (Pubitemid 46575367)
37. Schneider AR, Hammerstingl R, Heller M, Povse N, Murzynski L, Vogl TJ, et al. Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency?: a comparison with noninvasive exocrine pancreatic function tests. J Clin Gastroenterol 2006;40:851-5. (Pubitemid 44506932)
38. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34- (Suppl. 1):S62-9.
39. Aparisi QL, Sabater OL, Calvete CJ, Camps VB, Sastre BJ, Bautista RD, et al. Early carbohydrate metabolism dysfunction in chronic pancreatitis. Relation with the exocrine pancreatic function. Med Clin (Barc) 2001;117:561-6.
40. Schneider A, Lohr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol 2007;42:101-19. (Pubitemid 46404214)
41. Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009;169:1035-45.
42. Kristiansen L, Gronbaek M, Becker U, Tolstrup JS. Risk of pancreatitis according to alcohol drinking habits: a population-based cohort study. Am J Epidemiol 2008;168:932-7.
43. Tolstrup JS, Kristiansen L, Becker U, Gronbaek M. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. Arch Intern Med 2009;169:603-9.
44. Irving HM, Samokhvalov AV, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP 2009;10:387-92.
45. Andriulli A, Botteri E, Almasio PL, Vantini I, Uomo G, Maisonneuve P. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas 2010;39:1205-10.
46. Gonoi W, Akai H, Hagiwara K, Akahane M, Hayashi N, Maeda E, et al. Pancreas divisum as a predisposing factor for chronic and recurrent idiopathic pancreatitis: initial in vivo survey. Gut 2011;60:1103-8.
47. Bertin C, Pelletier AL, Vullierme MP, Bienvenu T, Rebours V, Hentic O, et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroenterol 2012;107:311-7.
48. Lerch MM, Riehl J, Mann H, Nolte I, Sieberth HG, Matern S. Sonographic changes of the pancreas in chronic renal failure. Gastrointest Radiol 1989;14:311-4. (Pubitemid 19201107)
49. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol 2005;39:709-16. (Pubitemid 41177092)
50. Rizk MK, Gerke H. Utility of endoscopic ultrasound in pancreatitis: a review. World J Gastroenterol 2007;13:6321-6.
51. Kloppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas 1993;8:659-70. (Pubitemid 23319154)
52. Becker V, Mischke U. Groove pancreatitis. Int J Pancreatol 1991;10:173-82.
53. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-5. (Pubitemid 26338792)
54. de las Heras-Castaño G, Castro-Senosiain B, Fontalba A, Lopez-Hoyos M, Sanchez-Juan P. Hereditary pancreatitis: clinical features and inheritance characteristics of the R122C mutation in the cationic trypsinogen gene (PRSS1) in six Spanish families. JOP 2009;10:249-55.
55. Aoun E, Chang CC, Greer JB, Papachristou GI, Barmada MM, Whitcomb DC. Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis. PLoS One 2008;3:e2003.
56. Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsvari B, Landt O, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008;40:78-82.
57. Masson E, Chen JM, Scotet V, Le MC, Ferec C. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet 2008;123:83-91.
58. Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 2001;48:70-4. (Pubitemid 32042644)
59. Casals T, Aparisi L, Martinez-Costa C, Gimenez J, Ramos MD, Mora J, et al. Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 2004;28:374-9. (Pubitemid 38509740)
60. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-52. (Pubitemid 28402088)
61. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339:653-8. (Pubitemid 28402089)
62. de CR, Ramos MD, Aparisi L, Garcia C, Mora J, Estivill X, et al. Independent contribution of common CFTR variants to chronic pancreatitis. Pancreas 2010; 39:209-15.
63. Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001;121:1310-9. (Pubitemid 33140448)
64. Derikx MH, Drenth JP. Genetic factors in chronic pancreatitis; implications for diagnosis, management and prognosis. Best Pract Res Clin Gastroenterol 2010;24:251-70.
65. Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2:252-61. (Pubitemid 38293313)
66. Ulrich CD. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology 2001;1:416-22. (Pubitemid 33681741)
67. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-6. (Pubitemid 44118845)
68. Naitoh I, Nakazawa T, Ohara H, Ando T, Hayashi K, Okumura F, et al. Comparative evaluation of the Japanese diagnostic criteria for autoimmune pancreatitis. Pancreas 2010;39:1173-9.
69. Kim MH, Kwon S. Diagnostic criteria for autoimmune chronic pancreatitis. J Gastroenterol 2007;42(Suppl. 18):42-9. (Pubitemid 46863937)
70. Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, de Las HG, Corts J, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 2005;54: 703-9. (Pubitemid 40559259)
71. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8. (Pubitemid 32204991)
72. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007;102:1646-53. (Pubitemid 47206688)
73. Takahashi N, Fletcher JG, Hough DM, Fidler JL, Kawashima A, Mandrekar JN, et al. Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dualphase CT. AJR Am J Roentgenol 2009;193:479-84.
74. Zamboni G, Luttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552-63. (Pubitemid 40104530)
75. Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol 2008;43:403-8. (Pubitemid 351997876)
76. Hirano K, Fukushima N, Tada M, Isayama H, Mizuno S, Yamamoto K, et al. Diagnostic utility of biopsy specimens for autoimmune pancreatitis. J Gastroenterol 2009;44:765-73.
77. Moon SH, Kim MH, Park DH, Hwang CY, Park SJ, Lee SS, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008;57:1704-12.
78. Okazaki K, Kawa S, Kamisawa T, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2010;45:249-65.
79. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol 2007; 42(Suppl. 18):39-41. (Pubitemid 46863936)
80. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40:352-8.
81. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009;58:1504-7.
82. Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009;104:2295-306.
83. Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010;139:140-8.
84. Kim HM, Chung MJ, Chung JB. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment. Pancreas 2010;39:555-60.
85. Ramesh H. Proposal for a new grading system for chronic pancreatitis: the ABC system. J Clin Gastroenterol 2002;35:67-70. (Pubitemid 34663353)
86. Otsuki M. Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems. J Gastroenterol 2003;38:315-26. (Pubitemid 36626266)
87. Bagul A, Siriwardena AK. Evaluation of the Manchester classification system for chronic pancreatitis. JOP 2006;7:390-6. (Pubitemid 44083110)
88. Buchler MW, Martignoni ME, Friess H, Malfertheiner P. A proposal for a new clinical classification of chronic pancreatitis. BMC Gastroenterol 2009;9:93.
89. Naruse S, Ishiguro H, Ko SB, Yoshikawa T, Yamamoto T, Yamamoto A, et al. Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency. J Gastroenterol 2006;41:901-8. (Pubitemid 44594232)
90. Teichmann J, Mann ST, Stracke H, Lange U, Hardt PD, Klor HU, et al. Alterations of vitamin D3 metabolism in young women with various grades of chronic pancreatitis. Eur J Med Res 2007;12:347-50. (Pubitemid 47365151)
91. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 2010;24:349-58.
92. Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007;56:1460-9. (Pubitemid 47517845)
93. Rebours V, Boutron-Ruault MC, Schnee M, Ferec C, Maire F, Hammel P, et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 2008;103:111-9.
94. Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates Jr LK, Perrault J, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442-6. (Pubitemid 27136736)
95. Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-21. (Pubitemid 38834045)
96. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766-81. (Pubitemid 43825802)
97. Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 2005;62:728-36. (Pubitemid 41503000)
98. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 2009;6:699-708.